Key statistics
On Friday, Grace Therapeutics, Inc (GRCE:NAQ) closed at 3.61, -8.33% below its 52-week high of 3.94, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.56 |
|---|---|
| High | 3.70 |
| Low | 3.48 |
| Bid | 3.63 |
| Offer | 3.90 |
| Previous close | 3.53 |
| Average volume | 55.31k |
|---|---|
| Shares outstanding | 15.47m |
| Free float | 11.29m |
| P/E (TTM) | -- |
| Market cap | 55.86m USD |
| EPS (TTM) | -0.3607 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Events & Activity
- GRCE:NAQ reported earnings of -0.14 for the period of the year 2026Q3.
- GRCE:NAQ price moved over +1.67% to 3.65
- GRCE:NAQ price falls below 50-day moving average to 3.50 at 14:30 GMT
- GRCE:NAQ price falls below 50-day moving average to 3.48 at 16:35 GMT
- GRCE:NAQ price rises above 15-day moving average to 3.65 at 14:38 GMT
